B BNTX
BioNTech SE
BIOTECHNOLOGY · HEALTHCARE
BioNTech SE, headquartered in Mainz, Germany, is a prominent biotechnology company focused on the development and commercialization of innovative immunotherapies targeting cancer and infectious diseases. Widely recognized for its pivotal collaboration with Pfizer that resulted in a pioneering COVID-...
$89.50
-1.43% ($1.30)
Volume
818,935
52W High
$124.00
52W Low
$79.52
Market Cap
$24.34B
What to Watch This Quarter
Based on historical dataConsensus EPS
-$2.44
Whisper EPS
-$2.44
0.1% above consensus
Last Quarter
-$1.95
Current Streak
2 Beats
Avg Surprise (4Q)
-8.54%
Next Earnings Report
Reports in 46 days
Price Chart
EPS History: Consensus vs Actual
Last 10 quartersPrice Movement Around Earnings
Q1 2026
May 11, 2026
1-Day:
+0.34%
Q1 2026
May 5, 2026
1-Day:
-0.25%
Q1 2026
May 4, 2026
1-Day:
-3.88%
Q4 2025
Mar 10, 2026
1-Day:
+8.28%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q3'25 | $1.52B | +22.0% | 90.2% | -3.1% | -$28.7M |
| Q2'25 | $260.8M | +102.6% | 70.7% | -192.1% | -$386.6M |
| Q1'25 | $182.8M | -2.6% | 54.2% | -292.2% | -$415.8M |
| Q4'24 | $1.19B | -19.5% | 79.5% | 12.5% | $259.5M |
| Q3'24 | $1.24B | +39.0% | 85.6% | 0.8% | $198.1M |
| Q2'24 | $128.7M | -23.3% | 53.5% | -750.7% | -$807.8M |
| Q1'24 | $187.6M | -85.3% | 68.5% | -270.4% | -$315.1M |
| Q4'23 | $1.48B | -65.4% | 87.9% | 35.6% | $457.9M |
Company Information
Symbol
BNTX
Company
BioNTech SE
Market Cap
$24.34B
Sector
HEALTHCARE
Next Earnings
Aug 3, 2026
Also Reporting Soon
Companies reporting earnings around the same time as BNTX
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in BIOTECHNOLOGY
Compare BNTX with competitors
Side-by-side earnings comparison